Physiologically based pharmacokinetic model for quinocetone in pigs and extrapolation to mequindox

References

• American Veterinary Medical Association (AMVA). 2001. Panel on euthanasia 2000 report of the AVMA panel on euthanasia. J Am Vet Med Assoc. 218:669–696.
   PubMed Web of Science ®Google Scholar
• Brocklebank JR, Namdari R, Law FC. 1997. An oxytetracycline-residue depletion study to assess the physiologically based pharmokinetic (PBPK) model in farmed Atlantic salmon. Can Vet J. 38:645–646.
   PubMed Web of Science ®Google Scholar
• Buur JL, Baynes RE, Craigmill AL. 2005. Development of a physiologic-based pharmacokinetic model for estimating sulfamethazine concentrations in swine and application to prediction of violative residues in edible tissues. Am J Vet Res. 66:1686–1693.
   PubMed Web of Science ®Google Scholar
• Buur JL, Baynes RE, Riviere JE. 2008. Estimating meat withdrawal times in pigs exposed to melamine contaminated feed using a physiologically based pharmacokinetic model. Regul Toxicol Pharmacol. 51:324–331.
   PubMed Web of Science ®Google Scholar
• Buur JL, Baynes RE, Smith G. 2006. Use of probabilistic modeling within a physiologically based pharmacokinetic model to predict sulfamethazine residue withdrawal times in edible tissues in swine. Antimicrob Agents Chemother. 50:2344–2351.
   PubMed Web of Science ®Google Scholar
• Chiesa OA, Bredow J, Nochetto C, Smith M, Heller D, Moulton K, Thomas MH. 2006a. Use of tissue-fluid correlations to estimate gentamicin residues in kidney tissue of Holstein steers. J Vet Pharmacol Ther. 29:99–106.
   PubMed Web of Science ®Google Scholar
• Chiesa OA, Bredow J, Smith M, Heller D, Condon R, Thomas MH. 2006b. Bovine kidney tissue/biological fluid correlation for penicillin. J Vet Pharmacol Ther. 29:299–306.
   PubMed Web of Science ®Google Scholar
• Clewell HJ, Gentry PR, Covington TR, Sarangapani R, Teeguarden JG. 2004. Evaluation of the potential impact if age- and gender-species pharmacokinetic differences on tissue dosimetry. Toxicol Sci. 79:381–393.
   PubMed Web of Science ®Google Scholar
• Corley RA, Bartels MJ, Carney EW, Weitz KK, Thrall KD. 2005. Development of a physiologically based pharmacokinetic model for ethylene glycol and its metabolite, glycolic acid, in rats and humans. Toxicol Sci. 85:476–490.
   PubMed Web of Science ®Google Scholar
• Corley RA, Gordon SM, Wallace LA. 2000. Physiologically based pharmacokinetic modeling of the temperature-dependent dermal absorption of chloroform by humans following bath water exposures. Toxicol Sci. 53:13–23.
   PubMed Web of Science ®Google Scholar
• Cortright KA, Wetzlich SE, Craigmill AL. 2009. A PBPK model for midazolam in four avian species. J Vet Pharmacol Ther. 32:552–565.
   PubMed Web of Science ®Google Scholar
• Craigmill AL. 2003. A physiologically based pharmacokinetic model for oxytetracycline residues in sheep. J Vet Pharmacol Ther. 26:55–63.
   PubMed Web of Science ®Google Scholar
• Duddy J, Hayden TL, Bourne DW. 1984. Physiological model for distribution of sulfathiazole in swine. J Pharm Sci. 73:1525–1528.
   PubMed Web of Science ®Google Scholar
• Grass GM, Sinko PJ. 2002. Physiologically-based pharmacokinetic model for oxytetracycline. Adv Drug Deliv Rev. 54:433–451.
   PubMed Web of Science ®Google Scholar
• Huang LL, Lin ZM, Zhou X. 2015a. Estimation of residue depletion of cyadox and its marker residue in edible tissues of pigs using physiologically based pharmacokinetic modeling. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 32:2002–2017.
   PubMed Web of Science ®Google Scholar
• Huang LL, Yin FJ, Pan YH, Chen DM, Li J, Wan D, Liu ZL, Yuan ZH. 2015b. Metabolism, distribution, and elimination of mequindox in pigs, chickens, and rats. J Agric Food Chem. 63:9839–9849.
   PubMed Web of Science ®Google Scholar
• Huang XJ, Ihsan A, Wang X, Dai MH, Wang YL, Su SJ, Xue XJ, Yuan ZH. 2009. Longterm dose dependent response of mequindox aldosterone, corticosterone and five steroidogenic enzyme mRNAs in the adrenal of male rats. Toxicol Lett. 191:167–173.
   PubMed Web of Science ®Google Scholar
• Ihsan A, Wang X, Huang XJ, Liu Y, Liu Q, Zhou W, Yuan ZH. 2010. Acute and subchronic toxicological evaluation of mequindox in Wistar rats. Regul Toxicol Pharmacol. 57:307–314.
   PubMed Web of Science ®Google Scholar
• Ihsan A, Wang X, Liu ZY, Huang XJ, Liu Y, Yu H, Zhang HF, Li TT, Yang CH, Yuan ZH. 2011. Longterm mequindox treatment induced endocrine and reproductive toxicity via oxidative stress in male Wistar rats. Toxicol Appl Pharmacol. 252:281–288.
   PubMed Web of Science ®Google Scholar
• Ihsan A, Wang X, Tu HG, Zhang W, Dai MH, Peng DP, Wang YL, Huang LL, Chen DM, Mannan SZ, et al. 2013b. Genotoxicity evaluation of mequindox in different shortterm tests. Food Chem Toxicol. 51:330–336.
   PubMed Web of Science ®Google Scholar
• Ihsan A, Wang X, Zhang W, Tu HG, Wang YL, Huang LL, Yuan ZH. 2013a. Genotoxicity of quinocetone, cyadox and olaquindox in vitro and in vivo. Food Chem Toxicol. 59:207–214.
   PubMed Web of Science ®Google Scholar
• James MG, Peter V, Emad EH, Dennis RG. 1993. Targeting anticancer drugs to the brain: physiologically pharmacokinetic model of oxantrazole following intraarterial administration to rat glioma-2 bearing rats. J Pharmacokinet Biopharm. 21:575–592.
   PubMedGoogle Scholar
• Law FC. 1992. A physiologically based pharmacokinetic model of oxytetracycline for salmonids. J Vet Pharmacol Ther. 8:33–43.
   Google Scholar
• Leavens TL, Tell LA, Clothier KA. 2012. Development of a physiologically based pharmacokinetic model to predict tulathromycin distribution in goats. J Vet Pharmacol Ther. 35:121–131.
   PubMed Web of Science ®Google Scholar
• Leavens TL, Tell LA, Kissell LW. 2014. Development of a physiologically based pharmacokinetic model for flunixin in cattle (Bos taurus). Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 31:1506–1521.
   PubMed Web of Science ®Google Scholar
• Li J, Huang LL, Pan YH, Liu ZY, Chen DM, Wang X, Tao YF, Liu ZL, Yuan ZH. 2014b. Tissue depletion of quinocetone and its five major metabolites in pigs, broilers, and carp fed quinocetone premix. J Agric Food Chem. 62:10348–10356.
   PubMed Web of Science ®Google Scholar
• Li J, Huang LL, Wang X, Pan YH, Liu ZY, Chen DM, Tao YF, Wu QH, Yuan ZH. 2014a. Metabolic disposition and excretion of quinocetone in rats, pigs, broilers, and carp. Food Chem Toxicol. 69:109–119.
   PubMed Web of Science ®Google Scholar
• Li JY, Zhou XZ, Li JS, Zhao RC, Miao XL, Zhang JY. 2005. The pharmacokinetics of quinocetone in pigs. Zhongguo Shou Yao Zazhi. 39:1–3.
   Google Scholar
• Liu Y, Huang LL, Wang YL, Yang B, Ishan A, Fang K, Peng DP, Liu ZL, Dai MH, Yuan ZH. 2010. Tissue depletion and concentration correlations between edible tissues and biological fluids of 3-amino-2-oxazolidinone in pigs fed with a furazolidone medicated feed. J Agric Food Chem. 58:6774–6779.
   PubMed Web of Science ®Google Scholar
• Liu YM. 2011. Pharmacokinetics and residual depletion of mequindox and its main metabolites in swine. Guangzhou: South China Agricultural University.
   Google Scholar
• Liu ZY, Huang LL, Chen DM, Dai MH, Tao YF, Wang YL, Yuan ZH. 2010. Application of electrospray ionization hybrid ion trap/time-of-flight mass spectrometry in the rapid characterization of quinocetone metabolites formed in vitro. Anal Bioanal Chem. 396:1259–1271.
   PubMed Web of Science ®Google Scholar
• Mercer HD, Baggot JD, Sams RA. 1977. Application of pharmacokinetic methods to the drug residue profile. Environ Health Toxicol. 2:787–801.
   Google Scholar
• Nestorov I. 2003. Whole body pharmacokinetic models. Clin Pharmacokinet. 42:883–908.
   PubMed Web of Science ®Google Scholar
• Riviere JE. 2011. Comparative pharmacokinetics: principles, techniques, and applications. 2nd ed. Ames (IA): Wiley-Blackwell.
   Google Scholar
• Teeguarden JG, Waechter JM, Clewell HJ, Covington RR, Barton HA. 2005. Evaluation of oral and intravenous route pharmacokinetics, plasma protein binding, and uterine tissue dose metrics of bisphenol A: a physiologically based pharmacokinetic approach. Toxicol Sci. 85:823–838.
   PubMed Web of Science ®Google Scholar
• Upton RN. 2008. Organ weights and blood flows of sheep and pig for physiological pharmacokinetic modeling. J Pharmacol Toxicol Methods. 58:198–205.
   PubMedGoogle Scholar
• Wang X, Zhang W, Wang YL, Peng DP, Ihsan A, Huang XJ, Yuan ZH. 2010. Acute and sub-chronic oral toxicological evaluations of quinocetone in Wistar rats. Regul Toxicol Pharmacol. 58:421–427.
   PubMed Web of Science ®Google Scholar
• Wang YY, Fang BF, Fan WD, Wang L. 2012. Pharmacokinetics of quinocetone and its major metabolites in swines. Zhongguo Xu Mu Shou Yi. 39:213–216.
   Google Scholar
• World Health Organization (WHO). 2010. Characterization and application of physiologically based pharmacokinetic models in risk assessment. Geneva: World Health Organization; p. 21–37.
   Google Scholar
• Xu LG, Zhao W, Li JQ, Huang J, Liao YQ. 2003. The treatment of mequindox on swine dysentery. Zhongguo Shou Yi Za Zhi. 39:278.
   Google Scholar
• Xu N, Huang LL, Liu ZY, Pan YH, Wang X, Yuan ZH. 2011. Metabolism of cyadox by the intestinal mucosa microsomes and gut flora of swine, and identification of metabolites by high-performance liquid chromatography combined with ion trap/time-of-flight mass spectrometry. Rapid Commun Mass Spectrom. 25:2333–2344.
   PubMed Web of Science ®Google Scholar
• Yang B, Huang LL, Fang K, Yuan ZH. 2013a. A physiologically based pharmacokinetic model for the prediction of the depletion of methyl-3-quinoxaline-2-carboxylic acid, the marker residue of olaquindox, in the edible tissues of pigs. J Vet Pharmacol Ther. 37:66–82.
   PubMed Web of Science ®Google Scholar
• Yang B, Huang LL, Wang YL, Liu Y, Tao YF, Chen DM, Liu ZL, Fang K, Chen YP, Yuan ZH. 2010. Residue depletion and tissue-plasma correlation of methyl-3-quinoxaline-2-carboxylic acid after dietary administration of olaquindox in pigs. J Agric Food Chem. 58:937–942.
   PubMed Web of Science ®Google Scholar
• Yang F, Huang XH, Li GH. 2013b. Estimating tulathromycin withdrawal time in pigs using a physiologically based pharmacokinetics model. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 30:1255–1263.
   PubMed Web of Science ®Google Scholar
• Yang F, Liu HW, Li M. 2012a. Use of a Monte Carlo analysis within a physiologically based pharmacokinetic model to predict doxycycline residue withdrawal time in edible tissues in swine. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 29:73–81.
   PubMed Web of Science ®Google Scholar
• Yang F, Sun N, Liu YM. 2014b. Estimating danofloxacin withdrawal time in broiler chickens based on physiologically based pharmacokinetics modeling. J Vet Pharmacol Ther. 38:174–182.
   PubMed Web of Science ®Google Scholar
• Yang F, Sun N, Sun YX. 2012b. A physiologically based pharmacokinetics model for florfenicol in crucian carp and oral-to-intramuscular extrapolation. J Vet Pharmacol Ther. 36:192–200.
   PubMed Web of Science ®Google Scholar
• Yang F, Yang YR, Wang L. 2014c. Estimating marbofloxacin withdrawal time in broiler chickens using a population physiologically based pharmacokinetics model. J Vet Pharmacol Ther. 38:1–10.
   PubMed Web of Science ®Google Scholar
• Yang W, Fu J, Xiao X, Yan H, Bao W, Wang D, Hao LP, Liu LG. 2013c. Quinocetone triggers oxidative stress and induces cytotoxicity and genotoxicity in human peripheral lymphocytes of both genders. J Sci Food Agric. 93:1317–1325.
   PubMed Web of Science ®Google Scholar
• Yang X, Zhou YF, Yu Y. 2014a. A physiologically based pharmacokinetic model for quinoxaline-2-carboxylic acid in rats, extrapolation to pigs. J Vet Pharmacol Ther. 38:55–64.
   PubMed Web of Science ®Google Scholar
• Young JF, Wosilait WD, Lueche RH. 2001. Analysis of methylmercury disposition in humans utilizing a PBPK model and animal pharmacokinetic data. J Toxicol Environ Health A. 63:19–52.
   PubMed Web of Science ®Google Scholar
• Yu M, Xu MJ, Liu Y, Yang W, Rong Y, Liu LG. 2013. Nrf2/ARE is the potential pathway to protect Sprague-Dawley rats against oxidative stress induced by quinocetone. Regul Toxicol Pharmacol. 66:279–285.
   PubMed Web of Science ®Google Scholar
• Yuan LG, Luo XY, Zhu LX. 2011. A physiologically based pharmacokinetic model for valnemulin in rats and extrapolation to pigs. J Vet Pharmacol Ther. 34:224–231.
   PubMed Web of Science ®Google Scholar
• Zhang HH, Wang X, Huang LL, Pan YH, Yuan ZH. 2015. Deoxidation rates play a critical role in DNA damage mediated by important synthetic drugs, quinoxaline 1, 4-dioxides. Chem Res Toxicol. 28:470–481.
   PubMed Web of Science ®Google Scholar
• Zhong JL, Wang L, Zhao N, Yu HM, Jia HQ, Lu XX, Wu ZY, Ding HZ. 2012. Study on residue depletion of quinocetone and its major metabolites in swine. Hua Nan Nong Ye Da Xue Xue Bao. 33:248–252.
   Google Scholar
• Zhou X. 2012. Physiologically based pharmacokinetic model for the marker residue of cyadox in pigs. Wuhan: Huazhong Agricultural University.
   Google Scholar